Akari Therapeutics Stock (NASDAQ: AKTX) stock price, news, charts, stock research, profile.
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Other companies in Akari Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS) and Bolt Biotherapeutics (NASDAQ:BOLT).
Akari Therapeutics has a consensus price target of $2.75.
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $2.36 last updated November 11, 2024 at 8:54 AM EST.
There are no upcoming dividends for Akari Therapeutics.
Akari Therapeutics’s H1 earnings are confirmed for Tuesday, November 26, 2024.
There is no upcoming split for Akari Therapeutics.
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.